EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
EMA expected to reject marketing authorization application for Aduhelm
The news follows a negative vote trend by the Committee for Medicinal Products for Human Use (CHMP) at their oral explanation meeting.
Brain health diplomacy: A necessity for dementia solutions
In this blog, the co-leaders of the Brain Health Diplomacy Working Group from The Global Brain Health Institute (GBHI), write about the necessity for brain health diplomacy in advancing better brain health.
Youth and dementia: Breaking down stigma through MECA exercises
Raymond Xiong writes about his inspiration behind creating and sharing MECA exercises, which incorporate music, gymnastics and cognitive activity, to improve the wellbeing of people living with dementia.
Six associations embark on Membership Development Programme at Alzheimer University
The annual Alzheimer University (AU) assists emerging Alzheimer and dementia associations.
A record-breaking World Alzheimer’s Month campaign
World Alzheimers Month 2021 has just ended and marks the most successful awareness raising campaign to date in its decade long history.
A second Alzheimer’s medication seeks FDA approval
Eisai’s lecanemab will represent the second anti-Amyloid Beta therapy to be evaluated by the FDA as a disease modifying treatment for early Alzheimer’s disease.
Over 41 million cases of dementia go undiagnosed across the globe – World Alzheimer Report reveals
This is the press release for the World Alzheimer Report 2021 'Journey through the diagnosis of dementia'
WHO launches global status report on public health response to dementia
This report reviews progress towards the implementation of the 7 action areas of the plan by Member States, WHO and civil society, and all those involved in tackling the dementia pandemic.